Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
TCT 24: The EVOLVED Trial
Author(s): Marc Dweck Added: 7 months ago
TCT Conference 2024 - Clinical outcomes of early intervention in patients with asymptomatic aortic stenosis (AS) did not impact the composite primary outcome of all cause mortality and unplanned AS related hospitalisation.Dr Marc Dweck (University of Edinburgh, Edinburgh, UK) joins us in this short interview filmed onsite at TCT Conference to discuss the findings from EVOLVED (NCT03094143;… View more

Imaging & Diagnostics

Intervention
ACC.24: The DEDICATE-DZHK6 Trial
Author(s): Moritz Seiffert Added: 1 year ago
ACC.24 — Investigator Dr Moritz Seiffert (University Heart and Vascular Center Hamburg, DE) joins us onsite at ACC to discuss the findings of the DEDICATE-DZHK6 Trial (NCT03112980).This randomized controlled, multi-center trial aimed to investigate whether transcatheter aortic valve implantation (TAVI) is non-inferior to surgical aortic valve replacement (SAVR) in patients with symptomatic severe… View more

Intervention
Aortic Valve Calcium, Aortic Stenosis and TAVI
Author(s): James Krzowski , Jonathan Weir-McCall , Luigia D’Errico , et al Added: 1 month ago

Imaging & Diagnostics

Intervention
ESC 24 Hot Line Discussion: The RHEIA Trial
Author(s): Harriette Van Spall , Helene Eltchaninoff Added: 9 months ago
ESC Congress 2024 — Transcatheter aortic valve replacement shows superiority over surgical aortic valve replacement for women with severe aortic stenosis.Host, Dr Harriette Van Spall (McMaster University, CA) sits down with Prof Helene Eltchaninoff (University Hospital of Rouen, FR) to discuss key findings from the RHEIA trial (NCT04160130; Optimapharm).This prospective, randomised study aims to… View more

Demographic

Intervention
EuroPCR 25: LANDMARK 1Y Outcomes
Author(s): Patrick W Serruys Added: 3 weeks ago
EuroPCR 25 - Novel Myval THV shows non-inferiority at one year compared to established valves in severe aortic stenosis.We are joined by Dr Patrick Serruys (Erasmus University Medical Center, Rotterdam, NL) to discuss key findings from the LANDMARK trial.This multinational, multicentric, randomized controlled trial compared the safety and effectiveness of the Myval THV Series against contemporary… View more

Intervention

Vascular Disease and Surgery
Transcatheter Aortic Valve Implantation Indications and Patient Selection
Author(s): Jonathan Curio , Henning Guthoff , Stephan Nienaber , et al Added: 5 days ago

Vascular Disease and Surgery
Revolutionising the Treatment of Severe Tricuspid Regurgitation with the EVOQUE System
Author(s): Philipp Lurz , Jorg Hausleiter , Maria Körber , et al Added: 1 year ago
In this programme, a leading faculty delve into the groundbreaking advancements in the treatment of severe tricuspid regurgitation with the innovative EdwardsEVOQUE Tricuspid Valve Replacement System. This session features an informative "Live in a Box" transcatheter tricuspid replacement valve case by Prof Jörg Hausleiter. It provides a comprehensive analysis of the patient selection criteria,… View more

Intervention
Gadolinium-guided Transcatheter Aortic Valve Implantation
Author(s): Bandar Alshehri , Hussein Alamri , Naif Alghasab , et al Added: 3 months ago

CV Disease in Special Populations

Intervention
EuroPCR 24: The NOTION-2 Study
Author(s): Ole De Backer Added: 1 year ago
EuroPCR 24 - We are joined onsite by Prof Ole De Backer (Rigshospitalet, DK) to discuss the findings from the NOTION-2 Study. (NCT02825134).NOTION-2 is a randomized, multicenter trial which aimed to investigate transcatheter aortic valve replacement (TAVR) versus surgical aortic valve replacement (SAVR) in 376 patients under 75 years of age with severe aortic valve stenosis in regard to intra-… View more

Intervention
Geographical Inequality in Access to Aortic Valve Intervention in England
Author(s): Suleman Aktaa , Noman Ali , Peter F Ludman , et al Added: 9 months ago

Intervention